Trust the Evidence

Trust the Evidence

Share this post

Trust the Evidence
Trust the Evidence
A Companion to Understanding Regulatory Data - Part 1

A Companion to Understanding Regulatory Data - Part 1

Redefining the “E” in EBM

Tom Jefferson's avatar
Carl Heneghan's avatar
Tom Jefferson
and
Carl Heneghan
Apr 22, 2024
∙ Paid
49

Share this post

Trust the Evidence
Trust the Evidence
A Companion to Understanding Regulatory Data - Part 1
3
3
Share

This is the first of two posts intended to ease the conceptual transition from biomedical journals and mainstream information to regulatory evidence. 

The article was originally published in 2018 as Jefferson T, Jørgensen LRedefining the ‘E’ in EBM. BMJ Evidence-Based Medicine 2018;23:46-47.

It was published when Carl was Editor-in-Chief and should provide a recap as to the rationale for preferring regulatory data in our reviews, especially for important and complex issues like the effects of Comirnaty and other global vaccines.

Please take your time reading and parsing its content, and as usual, let us know if anything is unclear. This post can also be read as a companion to our antivirals series.

Share

The philosopher of science, Thomas Kuhn (1), would probably have called our reliance on biomedical journal trial evidence a paradigm. It has served us well, allowing the building of the philosophical (2) and practical (3) backbone of evidence-based health care. However, like all paradigms, soon…

Keep reading with a 7-day free trial

Subscribe to Trust the Evidence to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Carl Heneghan
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share